Focus On Execution Pays Off Across Bristol’s New Product Portfolio

Q4 Sales Soared For Recent Launches, With One Exception

 
• By Mandy Jackson
  
Neon Q4, the fourth quarter of a fiscal year
Full-year revenue fell 2%, but Q4 rose 1% • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip